glp 1 dual agonist The Emerging Role of GLP-1 and GIP Receptor Agonists in Glycemic Management and Cardiovascular Risk Reduction TrimRX | GLP-1 vs GIP:

doi: 10.1038/s41467-022-28683-0 [DOI] [PMC free article] [PubMed] [Google Scholar] 216.Scheen AJ, Lefbvre PJ

A study in rats (Ramrez et al., 2018) has showed that the DPP4 inhibitor sitagliptin induces a lowering of fatty acid utilization in cardiomyocytes in favour of glucose

took another step toward adding a way for patients to hang onto their weight loss when the firm disclosed positive top-line data from the phase III Attain-Maintain trial with orforglipron, a once-daily oral small molecule GLP-1 receptor agonist

The index date and the time of study entry were defined as the kidney transplant date, identified using ICD-10-CM code Z94.0 and relevant procedure codes